Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-28

Clinical Trial Update: Effect of 12 Weeks Treatment With Tadalafil vs Placebo on Lower Urinary Tract Symptoms [Phase 4]

View source ↗

Summary

Phase 4 clinical trial comparing tadalafil to placebo for lower urinary tract symptoms in men with prostatic hyperplasia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • TADALAFIL (TADALAFIL)

Snippet

Sponsor: University of Florence | Conditions: Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 4 | Status: COMPLETED